Skip to main content
. 2022 Sep 30;14(19):4809. doi: 10.3390/cancers14194809

Figure 8.

Figure 8

Activation of EGFR with EGF partially reduced the sensitivity of BCa cells to cisplatin. (A) Cell viability CCK-8 assay. (B) Representative images of the Scratch Assay in 5637 and T24 cells. (C) Representative images of the transwell assay. (D) Protein expression levels of E-cadherin, cyclin D1, and cleaved-caspase-3. Data represent the mean ± standard deviation (SD) of three independent experiments (* p < 0.05, ** p < 0.01, *** p < 0.001).